| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
564,050,000 |
| Market
Cap: |
54.09(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.0959 - $0.0959 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Zomedica is a biopharmaceutical company targeting health and wellness solutions for the companion pet. Co.'s primary drug product candidate is ZM-007, an oral suspension formulation of metronidazole, targeting the treatment of acute diarrhea in small dog breeds and puppies under nine pounds or four kilograms. Co.'s second drug product candidate is ZM-012, a tablet formulation of metronidazole and a complementary formulation to ZM-007, targeting the treatment of acute diarrhea in dogs. Co.'s third drug product candidate is ZM-006, a transdermal gel formulation of methimazole targeting the chronic treatment of hyperthyroidism in cats.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
550,000 |
750,000 |
750,000 |
| Total Buy Value |
$0 |
$92,150 |
$130,580 |
$130,580 |
| Total People Bought |
0 |
2 |
2 |
2 |
| Total Buy Transactions |
0 |
5 |
7 |
7 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Powers Johnny |
|
• • – |
2023-12-15 |
4/A |
B |
$0.17 |
$16,500 |
D/D |
100,000 |
1,950,000 |
0.01 |
- |
|
| Powers Johnny |
|
• • – |
2023-12-15 |
4 |
B |
$0.17 |
$16,500 |
D/D |
100,000 |
1,950 |
0.01 |
- |
|
| Powers Johnny |
|
• • – |
2023-11-17 |
4 |
B |
$0.17 |
$16,600 |
D/D |
100,000 |
1,850,000 |
0.01 |
- |
|
| Heaton Larry C Ii |
CEO |
• • – |
2023-11-17 |
4 |
B |
$0.17 |
$16,600 |
D/D |
100,000 |
200,000 |
0.01 |
- |
|
| Powers Johnny |
|
• • – |
2023-11-15 |
4 |
B |
$0.17 |
$25,950 |
D/D |
150,000 |
1,750,000 |
0.01 |
- |
|
| Klass Russell Kevin |
Vice President of Sales |
• – – |
2023-11-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000,050 |
|
- |
|
| Heaton Larry C Ii |
CEO |
• • – |
2023-05-26 |
4 |
B |
$0.19 |
$19,090 |
D/D |
100,000 |
100,000 |
0.01 |
- |
|
| Powers Johnny |
|
• • – |
2023-05-25 |
4 |
B |
$0.19 |
$19,340 |
D/D |
100,000 |
1,600,000 |
0.01 |
- |
|
| Cohen Robert |
CEO |
• • – |
2021-06-30 |
4 |
AS |
$0.82 |
$447,343 |
D/D |
(543,750) |
0 |
|
- |
|
| Cohen Robert |
CEO |
• • – |
2021-06-30 |
4 |
OE |
$0.23 |
$125,063 |
D/D |
543,750 |
543,750 |
|
- |
|
| Cohen Robert |
CEO |
• • – |
2021-06-01 |
4 |
AS |
$0.81 |
$2,595,880 |
D/D |
(3,193,750) |
0 |
|
- |
|
| Cohen Robert |
CEO |
• • – |
2021-06-01 |
4 |
OE |
$0.19 |
$654,563 |
D/D |
3,193,750 |
3,193,750 |
|
- |
|
| Powers Johnny |
Director |
– • – |
2021-05-17 |
4 |
AS |
$0.78 |
$96,988 |
D/D |
(125,000) |
1,250,000 |
|
- |
|
| Powers Johnny |
Director |
– • – |
2021-05-17 |
4 |
OE |
$0.26 |
$32,500 |
D/D |
125,000 |
1,375,000 |
|
- |
|
| Cotter Ann |
CFO and Secretary |
• – – |
2021-05-03 |
4 |
AS |
$1.06 |
$20,611 |
D/D |
(19,444) |
0 |
|
- |
|
| Cotter Ann |
CFO and Secretary |
• – – |
2021-05-03 |
4 |
OE |
$0.11 |
$3,028 |
D/D |
19,444 |
8,333 |
|
- |
|
| Morley Stephanie |
President & CMO |
• – – |
2021-04-12 |
4 |
AS |
$1.16 |
$931,144 |
D/D |
(805,000) |
1,459,580 |
|
- |
|
| Morley Stephanie |
President & CMO |
• – – |
2021-04-12 |
4 |
OE |
$0.19 |
$272,950 |
D/D |
805,000 |
1,959,580 |
|
- |
|
| Cotter Ann |
CFO and Secretary |
• – – |
2021-04-12 |
4 |
AS |
$1.16 |
$67,473 |
D/D |
(58,332) |
0 |
|
- |
|
| Cotter Ann |
CFO and Secretary |
• – – |
2021-04-12 |
4 |
OE |
$0.11 |
$9,083 |
D/D |
58,332 |
25,000 |
|
- |
|
| Powers Johnny |
Director |
– • – |
2021-04-12 |
4 |
OE |
$0.16 |
$100,000 |
D/D |
625,000 |
1,250,000 |
|
- |
|
| Powers Johnny |
Director |
– • – |
2021-04-12 |
4 |
AS |
$1.16 |
$867,525 |
D/D |
(750,000) |
625,000 |
|
- |
|
| Powers Johnny |
Director |
– • – |
2021-04-12 |
4 |
OE |
$0.26 |
$340,000 |
D/D |
750,000 |
875,000 |
|
- |
|
| Macleod Christopher Ross |
Director |
– • – |
2021-02-03 |
4 |
S |
$1.10 |
$7,047 |
D/D |
(6,400) |
0 |
|
- |
|
| Macleod Christopher Ross |
Director |
– • – |
2020-07-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,400 |
|
-44% |
|
50 Records found
|
|
Page 1 of 2 |
|
|
